A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Clinical trial NCT05269004 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05269004
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2027-12-31
- Enrollment
- 1300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.